Literature DB >> 8442405

Experimental allergic myositis in SJL/J mice immunized with rabbit myosin B fraction: immunohistochemical analysis and transfer.

S Matsubara1, T Shima, M Takamori.   

Abstract

Experimental allergic myositis (EAM) was produced in SJL/J mice by inoculation with the myosin B fraction of the rabbit skeletal muscle, and the pathological changes were quantified. The myosin B fraction contains actin, myosin, tropomyosin and many other proteins, and has been known to induce severe EAM in guinea pigs. In the present model, macrophages and CD4+ lymphocytes predominated among the infiltrating cells. On the surface of muscle fibers and in the regions of cell infiltration deposition of the immunoglobulin G (IgG) and complement factor 3 was observed. EAM was transferred to normal mice by injecting the serum IgG of EAM. Depleting the recipients of complement before the transfer resulted in less-severe pathological changes. Morphologically, the EAM IgG showed an affinity for the nuclei, myofilaments, sarcolemma and blood vessels of mouse skeletal muscle. Biochemically EAM IgG contained antibodies against myosin, actin, troponin, M protein and other muscle proteins. These results indicated that IgG and complement play important roles in this model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8442405     DOI: 10.1007/bf00227760

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  29 in total

1.  PURIFICATION AND ANALYSIS OF FLUORESCEIN-LABELED ANTISERA BY COLUMN CHROMATOGRAPHY.

Authors:  H O MCDEVITT; J H PETERS; L W POLLARD; J G HARTER; A H COONS
Journal:  J Immunol       Date:  1963-04       Impact factor: 5.422

Review 2.  Polymyositis, dermatomyositis and inclusion-body myositis.

Authors:  M C Dalakas
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

3.  T-cell receptor alpha-chain variable-region haplotypes of normal and autoimmune laboratory mouse strains.

Authors:  P A Singer; R J McEvilly; R S Balderas; F J Dixon; A N Theofilopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  Macrophage migration inhibition studies of lymphocytes taken from guinea-pigs suffering from experimental polymyositis.

Authors:  P D Smith; T A Partridge
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

5.  The role of myofibrillar fraction of skeletal muscle in the production of experimental polymyositis.

Authors:  D Manghani; T A Partridge; J C Sloper
Journal:  J Neurol Sci       Date:  1974-12       Impact factor: 3.181

6.  Experimental myositis in rats. I. Histological and creatine phosphokinase changes, and passive transfer to normal syngeneic rats.

Authors:  M M Esiri; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

7.  Cytotoxic effect of antisera on 51Cr-labelled monolayers of skeletal muscle.

Authors:  R L Dawkins; G Loewi
Journal:  J Pathol       Date:  1973-05       Impact factor: 7.996

8.  Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method.

Authors:  R Warnke; R Levy
Journal:  J Histochem Cytochem       Date:  1980-08       Impact factor: 2.479

9.  Immune status of SJL-J mice in relation to age and spontaneous tumor development.

Authors:  N Haran-Ghera; M Ben-Yaakov; A Peled; Z Bentwich
Journal:  J Natl Cancer Inst       Date:  1973-05       Impact factor: 13.506

10.  Experimental autoimmune myositis in SJL/J mice.

Authors:  N L Rosenberg; S P Ringel; B L Kotzin
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

View more
  3 in total

1.  Development of an improved animal model of experimental autoimmune myositis.

Authors:  Juan Kang; Hong-Ya Zhang; Guo-Dong Feng; Dong-Yun Feng; Hong-Ge Jia
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 2.  Pathogenesis of neuroimmunologic diseases. Experimental models.

Authors:  C S Constantinescu; B Hilliard; T Fujioka; M K Bhopale; D Calida; A M Rostami
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

3.  Intravenous immunoglobulin prevents experimental autoimmune myositis in SJL mice by reducing anti-myosin antibody and by blocking complement deposition.

Authors:  J Wada; N Shintani; K Kikutani; T Nakae; T Yamauchi; K Takechi
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.